Clinical trials
Completed Phase 3 Pathologic Processes trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 4 |
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 4 |
| 2018 | 3 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bausch Health Americas, Inc. | 2 |
| Vertex Pharmaceuticals Incorporated | 2 |
| AO GENERIUM | 1 |
| AstraZeneca | 1 |
| Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| Mundipharma Research Limited | 1 |
| Neuroscience Trials Australia | 1 |
| Pfizer | 1 |
| The University of Texas Health Science Center, Houston | 1 |
| Ukraine Association of Biobank | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pathologic Processes | 14 |
| Digestive System Diseases | 5 |
| Fibrosis | 4 |
| Inflammation | 4 |
| Lung Diseases | 4 |
| Respiratory Tract Diseases | 4 |
| Cystic Fibrosis | 3 |
| Genetic Diseases, Inborn | 3 |
| Pancreatic Diseases | 3 |
| Candidemia | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.